Colorectal Cancer Alliance

“Facing colorectal cancer was a devastating and traumatic experience for me and for my family, and there is not a day that goes by that I don’t think about my experience. However, I live to talk about it, spread awareness, and help people going through it.” - Lori, Stage IV Survivor Starting today, the Alliance’s Young Survivors Week is a recognition of the immense burden of colorectal cancer on young people and a celebration of every ally in the struggle. Every patient deserves the opportunity to be a survivor, but we face a significant challenge. Young-onset CRC is a growing and devastating diagnosis. The number of patients is expected to increase 140% by 2030, and it recently became the deadliest cancer in men under 50 and second in women. The need to increase awareness, support, and research has never been greater. When you make a gift today, you will join Lori in supporting families facing colorectal cancer and survivors who are still affected every day. Make a gift 👉 https://bit.ly/24-YSW-Gift

Today, June 2nd, is National Cancer Survivors Day! Today we celebrate the more than 1.5 million colorectal cancer survivors in the U.S. Tell us who you're celebrating in the comments. #NationalCancerSurvivorsDay

June is National Cancer Survivors Month! A time when we celebrate strength, resilience, and survival. Join us in recognizing and honoring cancer survivors all month long. Find more ways to spread the word here 👉 https://bit.ly/24-NCSM #NationalCancerSurvivorsMonth

The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Yekaterina Zaytseva, PhD, of the University of Kentucky will receive $200,000 over two years. Zaytseva, an assistant professor of toxicology and cancer biology, will accelerate science to end colorectal cancer by investigating new drug combinations that effectively kill colorectal cancer cells with a BRAF mutation. This condition currently has a low response rate to existing treatments. Read more about this funding 👉 https://lnkd.in/eBCH3Mry

The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Kevin Van Der Jeught, Ph.D., of the University of Miami, will receive $200,000 over two years. Van Der Jeught, an assistant professor of microbiology and immunology, will accelerate science to end colorectal cancer by improving intratumoral mRNA vaccination strategies for colorectal cancer by targeting immune checkpoints to enhance anti-tumor immune responses. Read more about it here 👉 https://lnkd.in/euytx6VF

Our BlueHQ Patient Comfort Bags, delivered to patients at cancer centers across the country, contain Alliance resources, BlueHQ information, and supportive products for patients undergoing cancer treatment. During our initial pilot for the Comfort Bag program in March 2023, we distributed 500 comfort bags at 50 clinics in 17 states. By the end of 2023, we had distributed approximately 2,000 comfort bags throughout our community. The Alliance is grateful for the support from industry partners, including Takeda Oncology and Xilio Therapeutics, Inc., which will help us get closer to our goal of distributing at least another 2,000 comfort bags in 2024.

Register to join Yelena Y. Janjigian, MD, Shubham Pant, MD, and John Strickler, MD, for a Seminars & Tumor Board educational event, developed in collaboration with PVI, PeerView Institute for Medical Education and Cholangiocarcinoma Foundation and explore the nuances of treatment selection and delivery of HER2-targeting therapies. The expert panelists will utilize cases from their own practice to mimic real-life tumor board discussions and clinical decision-making, highlighting the critical role of broad HER2 testing in these solid GI tumor settings. Hear the latest safety/efficacy evidence on targeted therapies and gain skills for effective care coordination throughout the course of treatment, including facilitating patient engagement through shared decision-making strategies. Join us in Chicago TODAY, 5/31 at 6:30 PM CDT (or join virtually!) during #ASCO24, and expand your understanding of precision tactics for HER2-positive GI cancer care! https://bit.ly/2024GILi AstraZeneca Daiichi Sankyo US

The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Peter P. Lee, MD, of City of Hope, will receive $1 million over two years. Lee, chair of the Department of Immuno-Oncology at Beckman Research Institute of City of Hope, will accelerate science to end colorectal cancer by investigating a novel combination immunotherapy to treat metastatic MSS (microsatellite stable) colorectal cancer, which does not respond well to current treatments, including immunotherapy. Read more here 👉 https://lnkd.in/e4MXPx4m

Today is World Digestive Health Day. If you feel something isn't right with your digestive health, talk to your doctor. As Ashley said, ignorance is not bliss when it comes to a colon cancer diagnosis. Take our free screening quiz 👉 quiz.getscreened.org #WorldDigestiveHealthDay

Register to join Yelena Y. Janjigian, MD, Shubham Pant, MD, and John Strickler, MD, for a Seminars & Tumor Board educational event, developed in collaboration with PVI, PeerView Institute for Medical Education and Cholangiocarcinoma Foundation, and explore the nuances of treatment selection and delivery of HER2-targeting therapies. The expert panelists will utilize cases from their own practice to mimic real-life tumor board discussions and clinical decision-making, highlighting the critical role of broad HER2 testing in these solid GI tumor settings. Hear the latest safety/efficacy evidence on targeted therapies and gain skills for effective care coordination throughout the course of treatment, including facilitating patient engagement through shared decision-making strategies. Make your plans today to join us in Chicago on 5/31 at 6:30 PM CDT (or join virtually!) during #ASCO24, and expand your understanding of precision tactics for HER2-positive GI cancer care! https://bit.ly/2024GILi AstraZeneca Daiichi Sankyo US